Mizuho Boosts Corteva (NYSE:CTVA) Price Target to $82.00

Corteva (NYSE:CTVA) had its target price increased by Mizuho from $80.00 to $82.00 in a report issued on Tuesday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Mizuho’s target price would indicate a potential upside of 9.36% from the stock’s previous close.

Several other research analysts also recently commented on CTVA. Argus upgraded shares of Corteva to a “strong-buy” rating in a research report on Friday, January 16th. Rothschild & Co Redburn dropped their price target on shares of Corteva from $71.00 to $65.00 and set a “neutral” rating on the stock in a research report on Tuesday, November 11th. Bank of America increased their price objective on shares of Corteva from $80.00 to $82.00 and gave the company a “buy” rating in a research note on Thursday, January 8th. Zacks Research raised shares of Corteva from a “hold” rating to a “strong-buy” rating in a report on Thursday, January 22nd. Finally, Wolfe Research boosted their target price on Corteva from $81.00 to $86.00 and gave the company an “outperform” rating in a research note on Thursday, February 5th. Two analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and seven have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $82.30.

Corteva Stock Performance

Shares of NYSE CTVA opened at $74.98 on Tuesday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.96 and a current ratio of 1.43. The stock has a 50 day moving average price of $69.87 and a 200 day moving average price of $68.43. Corteva has a 52 week low of $53.40 and a 52 week high of $77.41. The stock has a market capitalization of $50.43 billion, a PE ratio of 47.46, a price-to-earnings-growth ratio of 2.56 and a beta of 0.75.

Corteva (NYSE:CTVA) last released its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.22. The company had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The business’s revenue was down 1.7% on a year-over-year basis. During the same period last year, the firm posted $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Analysts predict that Corteva will post 2.96 earnings per share for the current fiscal year.

Institutional Trading of Corteva

A number of institutional investors and hedge funds have recently bought and sold shares of CTVA. Total Investment Management Inc. bought a new position in shares of Corteva during the 2nd quarter valued at $27,000. Activest Wealth Management increased its holdings in shares of Corteva by 118.3% in the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after purchasing an additional 200 shares during the last quarter. Curat Global LLC increased its position in Corteva by 93.7% in the second quarter. Curat Global LLC now owns 370 shares of the company’s stock worth $28,000 after purchasing an additional 179 shares during the last quarter. JPL Wealth Management LLC purchased a new position in Corteva in the third quarter worth about $25,000. Finally, True Wealth Design LLC boosted its stake in shares of Corteva by 209.5% during the 3rd quarter. True Wealth Design LLC now owns 390 shares of the company’s stock worth $26,000 after purchasing an additional 264 shares during the period. 81.54% of the stock is currently owned by institutional investors.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.